Notícias e Atividades da Median Technologies

Median Technologies é uma empresa listada sob o símbolo ALMDT (FR).

Veja o organograma con seus 11 executivos principais

Biografias mais buscadas da Median Technologies

• Fredrik Brag, Chief Executive Officer and Director
• Kapil Dhingra, Director
• Tim Haines, Director

Recentes movimentos de executivos em Median Technologies

• Oran Muduroglu antes Chairman of the Board, agora é Chairman of the Board and President of Median eyonis  (Notícia publicada em 19 de fevereiro de 2026).
• Didric Cederholm, ingressou na Companhia como Director  (Notícia publicada em 3 de novembro de 2025).

Criar um alerta
para seguir os movimentos de executivos da Median Technologies.

Median Technologies possui 3.493 concorrentes concorrentes UnitedHealth Group (Estados Unidos), Kaiser Permanente (Estados Unidos) e HCA (Estados Unidos).

Popular M&A news in Saúde

• Hims & Hers adquiriu Eucalyptus (publicado em 2 de junho de 2026).
• Freeman Health System adquiriu Northwest Health (publicado em 2 de junho de 2026).
• Garner Health acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 29 de maio de 2026).

Outros contatos sugeridos na indústria do Saúde

• Ari Bousbib - Chairman and Chief Executive Officer da IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board da Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer da Royalty Pharma

Saiba mais sobre a indústria do Saúde

Últimos comunicados de imprensa de Median Technologies

• Launch of a capital increase - Median Technologies
• Median Technologies announces the availability of the preparatory documents for the Annual Shareholders’ Ordinary and Extraordinary General Meeting on June 10, 2026 - Median Technologies
• Disclosure of total number of voting rights and number of shares in the capital as of April 30, 2026 - Median Technologies
• Median Technologies reports full-year 2025 financial results and provides key Q1 2026 business highlights - Median Technologies
• Disclosure of total number of voting rights and number of shares in the capital as of March 31, 2026 - Median Technologies
• Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System - Median Technologies
• Median Technologies meets the eligibility conditions for the PEA-PME scheme - Median Technologies
• Disclosure of total number of voting rights and number of shares in the capital as of February 28, 2026 - Median Technologies
• Median Technologies to showcase eyonis® LCS, its AI/ML-based Software as a Medical Device for lung cancer screening, at the European Congress of Radiology - Median Technologies
• Median to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis® LCS - Median Technologies
• View more press releases Close

Redes sociais sobre Median Technologies

• Median Technologies na Wikipedia, Google News e Yahoo Finance
• Median Technologies na LinkedIn, X (Twitter) e YouTube